205 related articles for article (PubMed ID: 18983337)
1. Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?
Sarafidis PA; Lasaridis AN
J Cardiometab Syndr; 2008; 3(3):183-7. PubMed ID: 18983337
[TBL] [Abstract][Full Text] [Related]
2. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
[TBL] [Abstract][Full Text] [Related]
3. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
Sarafidis PA
Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.
Sarafidis PA; Ruilope LM
Am J Nephrol; 2006; 26(3):232-44. PubMed ID: 16733348
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of hypertension in the cardiometabolic syndrome.
Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
[TBL] [Abstract][Full Text] [Related]
8. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and cardiovascular risk in primary hypertension.
Ratto E; Leoncini G; Viazzi F; Vaccaro V; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S120-2. PubMed ID: 16565234
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia and insulin resistance, early cardiovascular risk factors in children with chronic kidney disease.
Lindblad YT; Axelsson J; Bárány P; Celsi G; Lindholm B; Qureshi AR; Carrea A; Canepa A
Blood Purif; 2008; 26(6):518-25. PubMed ID: 18987465
[TBL] [Abstract][Full Text] [Related]
12. Review: Insulin and endothelin: an interplay contributing to hypertension development?
Sarafidis PA; Bakris GL
J Clin Endocrinol Metab; 2007 Feb; 92(2):379-85. PubMed ID: 17118997
[TBL] [Abstract][Full Text] [Related]
13. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
Wahba IM; Mak RH
Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome: at the crossroads of cardiorenal risk.
Natali A; Pucci G; Boldrini B; Schillaci G
J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
[TBL] [Abstract][Full Text] [Related]
15. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
Lastra G; Manrique C; Sowers JR
Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
[TBL] [Abstract][Full Text] [Related]
16. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance?
Sarafidis PA; Bakris GL
Am J Nephrol; 2007; 27(1):44-54. PubMed ID: 17245074
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.
Reaven G
Endocrinol Metab Clin North Am; 2004 Jun; 33(2):283-303. PubMed ID: 15158520
[TBL] [Abstract][Full Text] [Related]
18. [Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance].
Rendina V; Iaccarino G; Iovino G; Morisco C; Vecchione C; Trimarco B
Cardiologia; 1994 Dec; 39(12 Suppl 1):295-8. PubMed ID: 7634286
[TBL] [Abstract][Full Text] [Related]
19. Targeting cardiovascular risk: early identification of insulin resistance.
Fortson J; Howe L; Harmon C; Sherrill WW
J Am Acad Nurse Pract; 2008 Jun; 20(6):319-25. PubMed ID: 18588659
[TBL] [Abstract][Full Text] [Related]
20. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
